Embedded AMIS-Deep Learning with Dialog-Based Object Query System for Multi-Class Tuberculosis Drug Response Classification

Author:

Prasitpuriprecha Chutinun,Pitakaso RapeepanORCID,Gonwirat SarayutORCID,Enkvetchakul Prem,Preeprem ThanawadeeORCID,Jantama Sirima Suvarnakuta,Kaewta ChutchaiORCID,Weerayuth Nantawatana,Srichok ThanatkijORCID,Khonjun SurajetORCID,Nanthasamroeng NatthapongORCID

Abstract

A person infected with drug-resistant tuberculosis (DR-TB) is the one who does not respond to typical TB treatment. DR-TB necessitates a longer treatment period and a more difficult treatment protocol. In addition, it can spread and infect individuals in the same manner as regular TB, despite the fact that early detection of DR-TB could reduce the cost and length of TB treatment. This study provided a fast and effective classification scheme for the four subtypes of TB: Drug-sensitive tuberculosis (DS-TB), drug-resistant tuberculosis (DR-TB), multidrug-resistant tuberculosis (MDR-TB), and extensively drug-resistant tuberculosis (XDR-TB). The drug response classification system (DRCS) has been developed as a classification tool for DR-TB subtypes. As a classification method, ensemble deep learning (EDL) with two types of image preprocessing methods, four convolutional neural network (CNN) architectures, and three decision fusion methods have been created. Later, the model developed by EDL will be included in the dialog-based object query system (DBOQS), in order to enable the use of DRCS as the classification tool for DR-TB in assisting medical professionals with diagnosing DR-TB. EDL yields an improvement of 1.17–43.43% over the existing methods for classifying DR-TB, while compared with classic deep learning, it generates 31.25% more accuracy. DRCS was able to increase accuracy to 95.8% and user trust to 95.1%, and after the trial period, 99.70% of users were interested in continuing the utilization of the system as a supportive diagnostic tool.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference91 articles.

1. World Health Organization (2020). Global Tuberculosis Report 2020.

2. Mignani, S., Tripathi, R.P., Chen, L., Caminade, A.-M., Shi, X., and Majoral, J.-P. (2018). New ways to treat tuberculosis using dendrimers as nanocarriers. Pharmaceutics, 10.

3. World Health Organization (2019). WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment.

4. World Health Organization (2022). WHO Operational Handbook on Tuberculosis: Module 4: Treatment: Drug-Susceptible Tuberculosis Treatment.

5. Drug resistant tuberculosis radiologic imaging manifestation. TB corner;Laya;Philippines,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3